OBJECTIVESType 2 diabetes mellitus is associated with various rheumatological manifestations that are debilitating and affect the quality of life. The present study is about prevalence of rheumatological manifestations in type 2 diabetics. METHODSThe current study is a cross sectional study with 100 patients of type 2 diabetics and 50 patients of age and sex matched non diabetics were examined for rheumatological manifestations during the period July 2008 to July 2010. The Rheumatological manifestations are documented and prevalence rates were calculated in percent of total cases in each group using Fisher's exact test and Chi-square test. RESULTSRheumatological manifestations were seen in 31% patients with type 2 diabetes mellitus compared to 16% in non-diabetics. Periarthritis of shoulder was seen in 18% diabetics compared to 4% in non-diabetics and was statistically significant. Diffuse idiopathic skeletal hyperostosis was observed in 3% of diabetics. Osteoarthritis of knee was noted in 8% of diabetics compared to 10% of non-diabetics. Carpal tunnel syndrome was seen in 3% of diabetics and 2% non-diabetics. The manifestations were more predominant in females 43.6% as compared to males 23%. CONCLUSIONRheumatological manifestations are more prevalent in type 2 diabetics than non-diabetics especially periarthritis of shoulder.
Background: Rhinocerebral mucormycosis is a dangerous fungal infection seen predominantly in immune-compromised patients. Many cases were detected and treated during the Second wave of the COVID-19 pandemic. In this case series, we are describing the imaging ndings of the Rhinocerebral mucormycosis. A retrospective descriptive study of 46 cases done in Materials And Methods: Sree Siddhartha medical college, Tumkur, Karnataka, India, CT and MRI images are reviewed, analyzed and documented. CT Results: and MRI images of 46post COVID -19 patients showed involvement of the sinuses with extension to orbit, face and central nervous system. Two cases showed intracranial extension. The contrast images delineated the extent of the disease. Signicant bony erosions were seen in most of the patients. Contrast CT and Conclusion: MRI scans showed the spectrum of ndings in Rhinocerebral mucormycosis to describe the extent of the disease and its complications.
Since its emergence in 2019, RT-PCR is a standard test for the detection of SARS-CoV-2 viral infection (COVID-19). Chest-CT scans are the preferred most common routine test to determine the spread and severity of the disease. The present study aims to demonstrate a comparative analysis of chest CT and RT-PCR as diagnostic tests for COVID-19 detection.In this prospective single-center study a total of 979 patients (Male= 614, female= 365) from Tumkur, Karnataka (India) who were suspected of novel coronavirus infection underwent both chest CT and RT-PCR assay.Patients with positive RT-PCR and abnormalities in chest CT images were identified. The patients with negative RT-PCR and positive chest-CT images and vice versa were screened for the accuracy of both techniques. Out of 979 patients, 674 (68.85%) patients had positive CT index scores, whereas 613 (62.61%) patients had positive RT-PCR tests. Most of the patients (47%) were from the age group 36-55 years with most of the population having hypertension (8.27%) and diabetes (6.44%). Corad score revealed 88.36% of patients (865) with high infection. In patients with negative RT-PCR reports (31.15%; 305/979), a positive CT index was observed in 7.25% of patients indicating higher sensitivity to this technique. A chest CT scan is superior in sensitivity for the detection of COVID-19 than that of RT-PCR. The CT scan can be used asa confirmatory diagnostic test for COVID-19 suspects whose RT-PCR test results are negative.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.